Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > EBIT

Arcus Biosciences Inc EBIT Chart (RCUS)

Arcus Biosciences Inc annual/quarterly EBIT from 2017 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Arcus Biosciences Inc EBIT for the quarter ending December 12, 2018 was $-13m a 1.13% decrease of 0m year over year
  • Arcus Biosciences Inc EBIT for the last 12 months ending December 12, 2018 was $-55m a -8.41% increase of 5m year over year
  • Arcus Biosciences Inc Annual EBIT for 2018 was $-55m a 2.58% decrease of -1m from 2017
  • Arcus Biosciences Inc Annual EBIT for 2017 was $-53m a 65.98% decrease of -35m from 2016
  • Arcus Biosciences Inc Annual EBIT for 2016 was $-18m
Other Income Statement Metrics:
  • Arcus Biosciences Inc EBITDA for the quarter ending December 12, 2018 was $-13m a 0.27% decrease of 0m year over year
  • Arcus Biosciences Inc Net Income for the quarter ending December 12, 2018 was $-12m a -5.36% increase of 1m year over year
  • Arcus Biosciences Inc Total Revenue for the quarter ending December 12, 2018 was $2m a 19.97% increase of 0m year over year
View Chart On Koyfin

Quarterly RCUS EBIT Data

12/2018$-13m
09/2018$-12m
06/2018$-16m
03/2018$-13m
12/2017$-13m
09/2017$-23m
06/2017$-10m
03/2017$-7m

Annual RCUS EBIT Data

2018$-55m
2017$-53m
2016$-18m